Which vaccines are in use in South Africa and how does our vaccination schedule measure up to international standards? In this #InTheSpotlight special briefing, Catherine Tomlinson unpacks the recent history and details the vaccines currently being used in the country.
There are 12 childhood vaccines in wide use in South Africa. This guide unpacks what you need to know about each of them.
Childhood immunisation programmes have saved many millions of lives and prevented much suffering. Yet, immunisation programmes have lost momentum over the last decade or so. In this Spotlight special briefing, Elri Voigt unpacks the available data and considers how immunisation efforts might be revitalised.
After a decade at the helm of the country’s primary health research funder, Professor Glenda Gray will focus again on doing the science. She tells Spotlight’s Biénne Huisman about her childhood, her passion for research, administering multi-million dollar grants, and a heated argument in the bathroom with an ANC bigwig.
During the height of the COVID-19 pandemic, many committees and organisations were working around the clock to prepare the country for the rollout of COVID-19 vaccines. Professor Hannelie Meyer, a pharmacist-turned-academic and later vaccine advocate, served on several of these committees. Elri Voigt spoke to Meyer about the pandemic, the mottos that guide her, and being an unapologetic workaholic.
The first vaccine to prevent severe lung infections, including pneumonia, in infants will save thousands of lives and reduce the burden on health systems of low- to middle-income countries, researchers say. Adele Baleta reports.
Almost 400 cases of measles have been reported across five provinces over the last four months. The NICD has advised that clinicians should be on high alert, as the opening of schools may lead to localised outbreaks. Elri Voigt reports on the current state of the outbreak, the potential outcomes, and what is being done to curtail the spread of measles in the country.
As a rebellious teenager growing up in the British town of Harpenden, Professor Helen Rees would sneak out to attend anti-apartheid talks. Today, she is a renowned scientist and chair of South Africa’s medicines regulator. Biénne Huisman chatted to Rees about her career, prioritising women’s reproductive health, and her role at the South African Health Products Regulatory Authority.
COVID-19 vaccine doses destined to be binned next month are “a shocking indictment” and questions need to be asked about just how effective the country’s vaccination drive has been, some public health experts say. Ufrieda Ho reports.
Earlier this month Cape Town-based vaccine company Afrigen announced a formal collaboration with the United States National Institute of Allergy and Infectious Diseases’ (NIAID’s) Vaccine Research Centre. Catherine Tomlinson unpacks what this deal may mean for local production of vaccines for COVID-19 and other diseases.
Indications are that the virus that causes COVID-19 is going to continue evolving and escaping the protection against infection people already have. Researchers are working on next-generation vaccines tailored to fight off specific versions of the virus, like the Omicron sub-lineages BA.4 and BA.5. But can these new vaccines be tested and produced fast enough to keep up with the rapidly changing virus? Aisha Abdool Karim asked some local experts.
Unlike regulators in the United States and Europe, the South African Health Products Regulatory Authority has not yet given the green light for any form of mix-and-match COVID-19 vaccine boosting. We take a look at the regulatory issues standing in the way of people in South Africa who received the Johnson & Johnson jab being offered Pfizer boosters.
